METLIFE INC (MET)
Financials / Life & Health Insurance
S&P 500$79.92
Below average on several measures. Research carefully.
Weak
Score based on 4 of 5 models — moderate confidence
Is METLIFE INC a Good Investment in 2026?
METLIFE INC (MET) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates METLIFE INC as Attractive (6/9). The Graham model is the least favorable, rating it Neutral. METLIFE INC currently trades above its estimated fair value of $59, suggesting limited upside at current prices. METLIFE INC ranks #36 out of 50 stocks in the Financials sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value. Eps growth of -19% may not justify the premium.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
46% above fair value
Lynch
Limited Data
High PEG — growth premium
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is METLIFE INC (MET) a good investment?
What is METLIFE INC's Piotroski F-Score?
Is MET overvalued or undervalued?
How does MET compare to other Financials stocks?
What do investment models say about MET?
Similar Stocks
Compare MET with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer